ファイザー・モデルナ併用可能　３回目接種、選択自由に―政府

　新型コロナウイルスワクチンの３回目の接種について、堀内詔子ワクチン担当相は１７日、一つの接種会場で使用するワクチンを基本的に１種類に限定する従来の方針を改め、米ファイザー製と米モデルナ製の同時使用を認めると明らかにした。東京都内で記者団に語った。
　２回目までと異なるワクチンを打つ交差接種も認められるため、モデルナ製の３回目での使用が可能になる見込みの来年２月以降、双方を併用する会場ではどちらを打つか接種希望者が自由に選べるようになる。（2021/11/17-17:28）

The Japanese government will allow a mix-and-match approach to novel coronavirus vaccines for third shots, Noriko Horiuchi, minister in charge of the vaccine rollout, said Wednesday.
   Japan will allow the simultaneous use of COVID-19 vaccines developed by U.S. drug giant Pfizer Inc. and U.S. biotechnology startup Moderna Inc. at a single vaccination venue, instead of its previous policy of limiting coronavirus vaccines to one brand at a single venue in principle, she said.
   The government will also approve cross-vaccination with a different vaccine from the one used in the first two doses.
   After the Moderna vaccine becomes available for booster shots in Japan in February at the earliest, people can choose which one they want to receive for their third shots at venues using both types of the vaccines.
   For the first two doses, the Pfizer is offered at mass vaccination venues run by municipalities and individual hospitals, while the Moderna vaccine is used for inoculation at workplaces, large venues managed by the Self-Defense Forces and mass vaccination sites run by prefectures.